Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
67 studies found for:    Medivation
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Enzalutamide;   Drug: exemestane;   Drug: Placebo (for enzalutamide)
2 Recruiting Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Conditions: Nonmetastatic Castration-Resistant Prostate Cancer;   Prostate Cancer;   Cancer of the Prostate
Interventions: Drug: Enzalutamide;   Drug: Placebo
3 Active, not recruiting Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
Condition: Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
Intervention: Drug: Enzalutamide
4 Active, not recruiting Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Bicalutamide
5 Completed A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
6 Unknown  Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
7 Recruiting Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Condition: Breast Cancer
Interventions: Drug: enzalutamide;   Drug: anastrozole;   Drug: exemestane;   Drug: fulvestrant
8 Completed Study of MDV3100 as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: MDV3100;   Drug: MDV3100 + Leuprolide + Dutasteride
9 Completed A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
Condition: Huntington Disease
Interventions: Drug: Dimebon;   Other: Placebo
10 Completed Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Dimebon
11 Terminated An Extension of the CONCERT Protocol (DIM18)
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
12 Unknown  Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
13 Active, not recruiting Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: MDV3100
14 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
15 Completed
Has Results
Determine the Effect of Enzalutamide (Formerly MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide to Identify Potential Predictors of Response or Resistance to Therapy
Condition: Metastatic Progressive Castration-resistant Prostate Cancer
Intervention: Drug: Enzalutamide
16 Active, not recruiting A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
Conditions: Prostate Cancer;   Hormone Refractory Prostate Cancer
Intervention: Drug: MDV3100
17 Completed An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Condition: Huntington Disease
Intervention: Drug: Dimebon (latrepirdine)
18 Terminated A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Condition: Moderate to Severe Alzheimer
Interventions: Drug: Dimebon (latrepirdine);   Drug: Placebo
19 Active, not recruiting
Has Results
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
Condition: Castration-Resistant Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
20 Active, not recruiting Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Abiraterone;   Drug: Placebo for Enzalutamide;   Drug: Prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years